Universal Biosensors Inc (UBI.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 629 | 632 | 874 | 652 | 667 |
| Accounts receivable | -177 | 446 | 43 | -784 | 87 |
| Other Working Capital | -192 | 228 | -689 | -1,633 | 3,313 |
| Other Operating Activity | -998 | -5,611 | -4,629 | -3,491 | -4,550 |
| Operating Cash Flow | $-738 | $-4,306 | $-4,402 | $-5,256 | $-484 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -522 | -637 | -133 | -273 | -189 |
| Investing Cash Flow | $-522 | $-637 | $-133 | $-273 | $-189 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -446 | N/A |
| Debt Issued | 0 | 0 | 0 | 1,002 | 0 |
| Debt Repayment | -1 | -228 | N/A | N/A | N/A |
| Common Stock Issued | 0 | -41 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 24,721 | 4 | 9 |
| Financing Cash Flow | $-1 | $-270 | $24,721 | $561 | $9 |
| Exchange Rate Effect | -265 | 133 | 231 | -117 | 63 |
| Beginning Cash Position | 28,351 | 33,431 | 13,014 | 18,099 | 18,699 |
| End Cash Position | 26,825 | 28,351 | 33,431 | 13,014 | 18,099 |
| Net Cash Flow | $-1,261 | $-5,213 | $20,186 | $-4,969 | $-663 |
| Free Cash Flow | |||||
| Operating Cash Flow | -738 | -4,306 | -4,402 | -5,256 | -484 |
| Capital Expenditure | -522 | -637 | -133 | -273 | -189 |
| Free Cash Flow | -1,260 | -4,943 | -4,535 | -5,530 | -672 |